The pharmaceutical company bounced 2 sessions ago from it's support level of 114.62$. The trend is still up and strong.
Buying at market price first target 118.90$ followed by 123.18$ then 128.54$. Stop loss at 10% from entry level, remember not to risk more than 2% of your capital.
Buying at market price first target 118.90$ followed by 123.18$ then 128.54$. Stop loss at 10% from entry level, remember not to risk more than 2% of your capital.
Kommentar:
second target reached so far